Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 5Leukemia, Myeloid, Acute 4Recurrence 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Ovarian Neoplasms 2Oligodendroglioma 2Lymphoma, B-Cell 2Leukemia 2Hodgkin Disease 2Astrocytoma 2Wilms Tumor 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Rhabdoid Tumor 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Nephroma, Mesoblastic 1Myelodysplastic Syndromes 1Multiple Myeloma 1Metastatic NUT Carcinoma 1Medulloblastoma 1

Interventions

Dexamethasone 8Cytarabine 7Cyclophosphamide 7venetoclax 6Vincristine 6Methotrexate 5merphos 4Rituximab 4Prednisone 4pegaspargase 3fludarabine phosphate 3dexamethasone acetate 3dexamethasone 21-phosphate 3Peripheral Blood Stem Cell Transplantation 3Filgrastim 3Calcium Dobesilate 3ruxolitinib 2prednylidene 2nelarabine 2deltacortene 2auricularum 2Whole-Body Irradiation 2Specimen Handling 2Pentetic Acid 2Mycophenolic Acid 2Injections 2Granulocyte Colony-Stimulating Factor 2Everolimus 2Etoposide 2Decitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × etoposide phosphate × Clear all
NCT00981799 2020-10-01

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1/2 Terminated
23 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Recurrence, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡